Article

IRS rules that eyeglasses, contact lenses are not taxable

The Internal Revenue Service (IRS) has ruled that eyeglasses and contact lenses are exempted from the medical device excise tax that will take affect on Jan. 1, 2013.

Washington, DC-The Internal Revenue Service (IRS) has ruled that eyeglasses and contact lenses are exempted from the medical device excise tax that will take affect on Jan. 1, 2013.

The IRS, in its final ruling on the excise tax earlier this month, outlined the regulations and definitions as to what medical devices would be taxed under the Health Care and Education Reconciliation Act of 2010 in conjunction with the Patient Protection and Affordable Care Act.

Within the 58-page document, the IRS cites the “retail exemption” (Section 4191 [b][2]) clause, which states that “the term ‘taxable medical device’ does not include eyeglasses, contact lenses, hearing aids, and any other medical device determined by the Secretary to be of a type that is generally purchased by the general public at retail for individual use.”

Under the proposed regulations, a device is considered to be non-taxable when the medical device is purchased by the general public “at retail for individual use” if the device is regularly available for purchase and used by consumers who are not medical professionals, and if the device’s design is not intended for use in a medical institution, office, or by medical professionals.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.